Close Menu
December 07, 2020
Sponsored by
Illumina

Increasing the Resolution: Implementing NGS at Probiotics Australia

Case Study

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Probiotics Australia is the first TGA accredited, cGMP, certified organic, probiotic API manufacturer in Australia who strives to innovate and raise the standard of the industry by employing genomics in two main areas, regulatory and R & D.

Sponsored by

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.